`
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________
`
`APOTEX INC.,
`Petitioner
`
`v.
`
`NOVO NORDISK A/S,
`PATENT OWNER
`_____________________
`
`CASE IPR2024-00631
`U.S. PATENT NO. 10,335,462
`ISSUED: JULY 2, 2019
`
`TITLE:
`USE OF LONG-ACTING GLP(cid:173)1 PEPTIDES
`
`PETITIONER’S POWER OF ATTORNEY
`IN RE PETITION FOR INTER PARTES REVIEW
`
`
`
`
`
`
`
`
`March 1, 2024
`
`DocuSign Envelope ID: 9E3DF89C-5E18-4F63-84B8-065AAA470EFB
`
`
`
`
`
`In accordance with 37 C.F.R. § 42.10(b), Petitioner, Apotex Inc., hereby
`
`appoints the following practitioners as their representative to act on their behalf in
`
`the above-identified petition for inter partes review, with full power to appoint an
`
`associate agent and to transact all business in the United States Patent and
`
`Trademark Office in connection therewith:
`
`Lead Counsel
`John J. Molenda (Reg. No. 47,804)
`jmolenda@steptoe.com
`
`Postal and Hand-Delivery Address:
`STEPTOE LLP
`1114 Avenue of the Americas
`New York, NY 10036
`
`Back-Up Counsel
`Lawrence Kass (Reg. No. 40,671)
`lkass@steptoe.com
`
`
`Tyler Doh (Reg. No. 80,274)
`tdoh@steptoe.com
`
`Michael I. Green (Reg. No. 80,436)
`migreen@steptoe.com
`
`Postal and Hand-Delivery Address:
`STEPTOE LLP
`1114 Avenue of the Americas
`New York, NY 10036
`
`
`
`Apotex Inc. hereby appoints additional practitioners associated with
`
`Steptoe LLP who appear in any future updated mandatory notices, and any
`
`attorneys from Steptoe LLP admitted pro hac vice in this matter.
`
`
`
`
`
`1
`
`DocuSign Envelope ID: 9E3DF89C-5E18-4F63-84B8-065AAA470EFB
`
`
`
`
`
`The individual signing below has the authority to execute this document on
`
`behalf of Petitioner, Apotex Inc.
`
`Apotex Inc.
`
`Signature:
`
`Name:
`Title:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`DocuSign Envelope ID: 9E3DF89C-5E18-4F63-84B8-065AAA470EFB
`
`Kevin Zive
`
`Vice President- Global General Counsel and Head of IP
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that, in accordance with 37 C.F.R. § 42.6(e) and 37
`
`C.F.R. § 42.105, and with Patent Owner’s consent, electronic service of
`
`PETITIONER’S POWER OF ATTORNEY IN RE PETITION FOR INTER
`
`PARTES REVIEW was made on Patent Owner to the following email addresses:
`
`J. Steven Baughman
`Megan Raymond
`Michael F. Milea
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`steve.baughman@groombridgewu.com
`megan.raymond@groombridgewu.com
`mike.milea@groombridgewu.com
`Novo-Semaglutide-IPR@groombridgewu.com
`
`
`
`/s/ John J. Molenda
`John J. Molenda (Reg. No. 47,804)
`Lawrence Kass (Reg. No. 40,671)
`Tyler Doh (Reg. No. 80,274)
`Michael I. Green (Reg. No. 80,436)
`STEPTOE LLP
`1114 Avenue of the Americas
`New York, NY 10036
`Tel: (212) 506-3900
`
`Counsel for Apotex
`
`Dated: March 1, 2024
`
`
`
`
`3
`
`DocuSign Envelope ID: 9E3DF89C-5E18-4F63-84B8-065AAA470EFB
`
`